Jing Meng

1.0k total citations
25 papers, 776 citations indexed

About

Jing Meng is a scholar working on Clinical Biochemistry, Epidemiology and Molecular Biology. According to data from OpenAlex, Jing Meng has authored 25 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Biochemistry, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Jing Meng's work include Advanced Glycation End Products research (7 papers), CO2 Sequestration and Geologic Interactions (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Jing Meng is often cited by papers focused on Advanced Glycation End Products research (7 papers), CO2 Sequestration and Geologic Interactions (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Jing Meng collaborates with scholars based in China, Japan and United States. Jing Meng's co-authors include Shigeo Takebayashi, Chunhong Ma, Ying Ju, Robert E. Braun, Anne R. Greenlee, Chloe J. Taub, Lifen Gao, Xiaoyan Wang, Xiaoning Zhang and Nan Hou and has published in prestigious journals such as Journal of Hepatology, American Journal Of Pathology and Cell Host & Microbe.

In The Last Decade

Jing Meng

24 papers receiving 762 citations

Peers

Jing Meng
Annette Uittenbogaard United States
Matthew Gage United Kingdom
Renqi Yuan United States
Hui Guo China
Qiuhong Zhang United States
Li H. Gu United States
Annette Uittenbogaard United States
Jing Meng
Citations per year, relative to Jing Meng Jing Meng (= 1×) peers Annette Uittenbogaard

Countries citing papers authored by Jing Meng

Since Specialization
Citations

This map shows the geographic impact of Jing Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Meng more than expected).

Fields of papers citing papers by Jing Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Meng. The network helps show where Jing Meng may publish in the future.

Co-authorship network of co-authors of Jing Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Meng. A scholar is included among the top collaborators of Jing Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Meng. Jing Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qi, et al.. (2025). Procyanidin B2 attenuates microvascular dysfunction in diabetic retinopathy via inhibition of caspase-1/GSDMD mediated pyroptosis. Journal of Ethnopharmacology. 344. 119528–119528. 3 indexed citations
2.
Meng, Jing, et al.. (2025). Quantitative assessment and transmission mechanisms of technical risks in CO 2 geological storage using social network analysis. Georisk Assessment and Management of Risk for Engineered Systems and Geohazards. 20(1). 124–140.
3.
Liu, Qun, Chaoqun Liu, Qi Liu, et al.. (2024). Ferroptosis Contributes to Microvascular Dysfunction in Diabetic Retinopathy. American Journal Of Pathology. 194(6). 1078–1089. 17 indexed citations
4.
Liu, Suyan, Zhong Xian, Yong Zhao, et al.. (2021). Quantitative Determination and Toxicity Evaluation of Aristolochic Acid Analogues in Asarum heterotropoides F. Schmidt (Xixin) and Traditional Chinese Patent Medicines. Frontiers in Pharmacology. 12. 761593–761593. 21 indexed citations
5.
Wu, Aiping, Lulan Wang, Hangyu Zhou, et al.. (2021). One year of SARS-CoV-2 evolution. Cell Host & Microbe. 29(4). 503–507. 46 indexed citations
6.
Meng, Jing, et al.. (2020). Hydrogen sulfide alleviates cigarette smoke-induced COPD through inhibition of the TGF-β1/smad pathway. Experimental Biology and Medicine. 245(3). 190–200. 25 indexed citations
7.
Meng, Jing, Hongqin Xu, Jing Jiang, et al.. (2019). A retrospective serological survey of hepatitis B virus infection in Northeast China. BMC Infectious Diseases. 19(1). 440–440. 12 indexed citations
8.
Liu, Xu, Jing Meng, Hongqin Xu, & Junqi Niu. (2019). Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma. Medicine. 98(17). e15414–e15414. 15 indexed citations
9.
Dai, Yifei, Jing Meng, Xin-Liang Du, et al.. (2017). The pharmacological activities and mechanisms of artemisinin and its derivatives: a systematic review. Medicinal Chemistry Research. 26(5). 867–880. 48 indexed citations
10.
Deng, Hongwei, Yuan Tian, Xiaojuan Zhou, Xiaoming Zhang, & Jing Meng. (2016). Effect of Bilberry Extract on Development of Form-Deprivation Myopia in the Guinea Pig. Journal of Ocular Pharmacology and Therapeutics. 32(4). 196–202. 17 indexed citations
11.
Huang, Haipeng, Jing Meng, Lin Meng, et al.. (2012). [Biodiversity of culturable halotolerant and halophilic bacteria isolated from saline-alkaline soils in Songnen Plain].. PubMed. 52(10). 1187–94. 9 indexed citations
12.
Meng, Jing, Anne R. Greenlee, Chloe J. Taub, & Robert E. Braun. (2011). Sertoli Cell-Specific Deletion of the Androgen Receptor Compromises Testicular Immune Privilege in Mice1. Biology of Reproduction. 85(2). 254–260. 74 indexed citations
13.
Ju, Ying, Nan Hou, Jing Meng, et al.. (2010). T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. Journal of Hepatology. 52(3). 322–329. 196 indexed citations
14.
Morimoto, Takamasa, Takao Yasuhara, Masahiro Kameda, et al.. (2010). Striatal Stimulation Nurtures Endogenous Neurogenesis and Angiogenesis in Chronic-Phase Ischemic Stroke Rats. Cell Transplantation. 20(7). 1049–1064. 42 indexed citations
15.
Meng, Jing, Shu Quan, Li Gao, et al.. (2007). Expression of Human TIM‐1 and TIM‐3 on Lymphocytes from Systemic Lupus Erythematosus Patients. Scandinavian Journal of Immunology. 67(1). 63–70. 64 indexed citations
16.
Meng, Jing, et al.. (2001). Carboxymethyllysine in Dermal Tissues of Diabetic and Nondiabetic Patients with Chronic Renal Failure: Relevance to Glycoxidation Damage. ˜The œNephron journals/Nephron journals. 88(1). 30–35. 19 indexed citations
17.
Meng, Jing, et al.. (2000). Effects of Advanced Glycation End-products on the Proliferation and Fibronectin Production of Smooth Muscle Cells. Journal of Atherosclerosis and Thrombosis. 7(3). 169–176. 58 indexed citations
18.
Meng, Jing, Noriyuki Sakata, Shigeo Takebayashi, et al.. (1998). Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis. 136(2). 355–365. 46 indexed citations
19.
Miyamoto, Koji, et al.. (1998). Oxidative damage of vascular smooth muscle cells by the glycated protein–cupric ion system. Atherosclerosis. 136(2). 263–274. 14 indexed citations
20.
Meng, Jing, et al.. (1995). Nonenzymatic glycation and extractability of collagen in human atherosclerotic plaques. Atherosclerosis. 116(1). 63–75. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026